A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain
Sign Up to like & getrecommendations! Published in 2017 at "Cell Transplantation"
DOI: 10.3727/096368916x693563
Abstract: C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12. Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone… read more here.
Keywords: cx549; cxcr4 antagonist; stroke brain; novel cxcr4 ... See more keywords